Results 211 to 220 of about 36,737 (275)

Renal Involvement in Monoclonal Gammopathies [PDF]

, 2010
Carvalho, D, Carvalho, F, Ferreira, A, Ferreira, AC, Galvão, MJ, Nolasco, F, Santos, MC, Viana, H   +7 more
core  

Diagnostic pathways, cardiac manifestations and outcomes in light chain amyloidosis: analysis of a US claims database. [PDF]

Open Heart
Lyons G, Thompson J, Lousada I, Catini J, Manwani R, Maurer MS.   +5 more
europepmc   +1 more source

Diastolic Dysfunction Unveiling Cardiac Light-Chain Amyloidosis: A Case Report. [PDF]

Med Res Arch
Saha S, Mondal R, Deb S, Sarkar B, Benito-León J.   +4 more
europepmc   +1 more source

Development and validation of an early prediction model for cardiac death risk in patients with light chain amyloidosis: a multicenter study. [PDF]

Cardiooncology
Pang N, Tian Y, Chi H, Fu X, Li X, Wang S, Pan F, Wang D, Xu L, Luo J, Liu A, Liu X.   +11 more
europepmc   +1 more source

Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre Experience. [PDF]

Cancers (Basel)
Alejo E, Agulló C, Puertas B, Eiros R, Rey-Búa B, Barnés C, Rodríguez-González M, López-Corral L, Santos-Briz Á, Escalante F, Pérez-García ML, Jiménez-Cabrera S, Gutiérrez NC, Puig N, Mateos MV, González-Calle V.   +15 more
europepmc   +1 more source

Big data analytics & pathology services in NHS: achieving step changes in capacity [PDF]

, 2016
Douglas, S, Laffan, M, Littlewood, R
core  

Monoclonal Gammopathy of Multisystemic Significance: A Challenging Diagnosis of Light Chain Amyloidosis. [PDF]

Cureus
Owolabi O, Yera HO, Jenkins K, Pakala V, Kundu S.   +4 more
europepmc   +1 more source

Rapid identification of daratumumab interference with M-protein detection using MALDI-TOF mass spectrometry: a case study involving renal light chain amyloidosis. [PDF]

Pract Lab Med
Luo HL, Xu A, Ji L.
europepmc   +1 more source

A mouse model of cardiac immunoglobulin light chain amyloidosis reveals insights into tissue accumulation and toxicity of amyloid fibrils. [PDF]

Nat Commun
Martinez-Rivas G, Ayala MV, Bender S, Codo GR, Swiderska WK, Lampis A, Pedroza L, Merdanovic M, Sicard P, Pinault E, Richard L, Lavatelli F, Giorgetti S, Canetti D, Rinsant A, Kaaki S, Ory C, Oblet C, Pollet J, Naser E, Carpinteiro A, Roussel M, Javaugue V, Jaccard A, Bonaud A, Delpy L, Ehrmann M, Bridoux F, Sirac C.   +28 more
europepmc   +1 more source

Novel targeted therapies for immunoglobulin light chain amyloidosis: latest updates from the 2024 ASH annual meeting. [PDF]

J Hematol Oncol
Bu Q, Zhu HH, Chen W.
europepmc   +1 more source